Masimo Stock News

MASI earnings call for the period ending December 31, 2021.

Masimo (MASI) will acquire Sound United, an innovator of premium, high-performance audio products, for ~$1.025B.MASI will leverage Sound United’s expertise across consumer channels…

Masimo press release (MASI): Q4 Non-GAAP EPS of $1.21 beats by $0.11.Revenue of $327.58M (+11.0% Y/Y) beats by $6.83M.2022 Guidance: Product revenue increasing to $1,350.0…

IRVINE, Calif.--(BUSINESS WIRE)--Masimo (Nasdaq: MASI) today announced its financial results for the fourth quarter and full-year ended January 1, 2022. Fourth Quarter 2021 Results: Product revenue increased 11.0% to $327.6 million, or 11.5% on a constant currency basis, compared to $295.1 million in the fourth quarter of 2020. Excluding handheld and fingertip pulse oximeters, shipments of noninvasive technology boards and instruments were 76,000 in the fourth quarter of 2021. For the fourth qu

Masimo's (MASI) CEO Joe Kiani on Q4 2021 Results - Earnings Call Transcript

Masimo (NASDAQ:MASI) is scheduled to announce Q4 earnings results on Tuesday, Feb. 15, after market close.The consensus EPS estimate is $1.10 (+12.2% Y/Y)

The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.

Pune, India, Feb. 07, 2022 (GLOBE NEWSWIRE) -- The global pulse oximeters market is likely to grow in the coming years due to increasing usage clearances from the Food and Drug Administration (FDA). According to a report published by Fortune Business Insights, titled "Pulse Oximeters: Global Market Analysis, Insights and Forecast, 2018-2025," the market is likely to reach US$ 2,657.6 Mn by the end of 2025. Fortune Business Insights states that the market was valued at US$ 1,587.3 Mn in 2017 and will exhibit a CAGR of 6.7% in the forecast period. In the report, Fortune Business Insights has profiled a few companies that are operating in the global pulse oximeter market. Some of the leading companies that have been identified as significant growth contributors are GENERAL ELECTRIC COMPANY, Koninklijke Philips N.V, Masimo, Messe Düsseldorf GmbH, VYAIRE, Opto Circuits (India) Limited, Medtronic, Omron Healthcare, Inc., Nonin, and B Smiths Group plc. Get Sample PDF Brochure: https://www.fortunebusinessinsights.com/enquiry/sample/pulse-oximeters-market-100528 Masimo''s Approval for Radius PPG to Trigger Growth In 2019, Masimo received clearance for its latest pulse oximeter.

Stocks Analysis by Zacks Investment Research covering: NVIDIA Corporation, Masimo Corporation, Boston Beer Company Inc. Read Zacks Investment Research''s latest article on Investing.com

Masimo (MASI) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road

Investors continue to be optimistic about Masimo (MASI) owing to its focus on patient monitoring.

When screening the market for value opportunities, investors may want to consider stocks that represent companies with high profitability and robust financial conditions. These qualities are represent

Masimo's (MASI) solid full-year results likely to have been boosted by strong product sales.

Masimo (MASI) expects that its product revenue for FY21 will range from $1.235 to $1.24B which marks growth of ~8% to 8.4% and constant currency growth of 7.3% to 7.7%,